Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJB1 pseudogene 1 (DNAJB1P1, psiHSP40) is a nonfunctional genomic sequence in humans that is similar to, but distinct from, the protein-coding heat shock protein gene DNAJB1. As a pseudogene, DNAJB1P1 does not produce a biologically active protein and has no reported role in normal physiology or disease. It is not considered a therapeutic target and should not be confused with DNAJB1, an active molecular chaperone involved in protein folding, cellular stress response, and implicated in cancer disease mechanisms[1][5]. If you require target information relevant to disease or therapeutics, the functional protein-coding gene DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1) is the appropriate entity for further inquiry[1][2][4]. DNAJB1P1 is not therapeutically relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAJB1 pseudogene 1 (DNAJB1P1).